kewal handa pfizer Speech About Pharam Sector

Pharma Sector Stocks in crisis, what will happen next

Try to understand the pharma Stock’s Outlook. How much has been the tension of the US FDA and what are the new challenges, it is telling that the former MD of Pfizer, kewal Handa. In fact, the US generic market has worsened faster than expected. In the US generic market, prices of medicines have dropped by 10-12 percent compared to the 7-8 percent estimate. Not only is this, in the next two years, the FDA approval fee in the US likely to increase by 50 percent. Increasing the approval from the US will increase the FDA compatibility. Also plan to land in Amazon Pharmacy market. At the same t...
Read More